Diabetes and CKD: is it all about managing glucose?

10' education - July 1, 2020 - Prof. Melanie Davies, MD - University of Leicester, UK

Video navigation menu

The interrelationship between T2DM, CVD (including HF) and CKD 00:33
GLP-1: the conductor of the diabetes orchestra 02:37
Management of T2DM patients with ASCVD, HF or CKD 03:58
Members of the GLP-1RA class and their effects 08:05
Combined use of SGLT2i and GLP-1RAs 10:22

In the ADA-EASD Consensus Report update of 2019 it is stated that:

A. baseline HbA1c should be taken into account when considering GLP-1RAs or SGLT2i
B. target HbA1c should be taken into account when considering GLP-1RAs or SGLT2i
C. when ASCVD predominates, all members of the GLP-1RA class can be considered
D. GLP-1RAs or SGLT2i should be considered for management of weight and hypoglycemia

Educational information

This lecture by prof. Melanie Davies was part of the EBAC-accredited symposium "Cardiorenal cross-talk in diabetes: The preventive challenge in DKD for GLP-1RA" held during ERA EDTA Virtual Congress 2020.

Faculty

Melanie Davies, MD, is Professor of Diabetes Medicine at the University of Leicester, UK.

Disclosures

This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.

Funding

Funding for this educational program was provided by an unrestricted educational grant from Novo Nordisk A/S.

View slides of the presentation Click here for the meeting report

The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.